Decoding Hospital M&A Values in India: What Drives the Deals?

Mergers and Acquisitions
Mergers and Acquisitions
Following a significant surge in mergers and acquisitions within the hospital industry in FY 2024, this trend continues strongly into FY 2025. The Indian hospital sector is experiencing a substantial wave of M&A and strategic expansions. For stakeholders, investors, and industry observers, understanding the valuation aspects of these deals is now more critical than ever. This blog post delves into the valuation dynamics within the Indian hospital M&A space, highlighting key considerations, providing examples, and exploring the reasons behind varying valuations.

What Goes into Valuing a hospital: Key Factors

Putting a price tag on a hospital is more than just looking at the numbers. It involves considering several unique aspects of the healthcare business:

Financial Health: This is the foundation. We look at how much money the hospital makes (revenue growth), how profitable it is (EBITDA margins), its cash flow, and the return it provides on investments. Effective hospital revenue management, along with steady income, good cost management, and strong profits, generally makes a hospital worth more.

Operational strength: Efficiency matters. Factors like how many beds are occupied, how much revenue each occupied bed generates (ARPOB), patient numbers, and the smooth operation of clinical and administrative processes all play a role. Better efficiency usually means a higher valuation.

Quality Clinical Leadership & Ownership: The presence of highly skilled medical professionals, particularly when they have an ownership interest, provides stability and confidence, positively impacting the hospital’s value

Quality of Facilities and Services: The condition of the hospital buildings, the modernity of its medical equipment, and the technology it uses are important. Hospitals offering advanced and specialized treatments that attract more patients and can charge premium prices tend to be valued higher.

Market Standing: A hospital’s share of the local market, its brand reputation, and its position compared to other healthcare providers in the area are crucial. Hospitals with a strong local presence and brand often get better valuations.

Following the Rules: The healthcare industry is heavily regulated. Hospitals that consistently comply with regulations, have important accreditations (like NABH), and have a clean record are more valuable. Any regulatory problems can lower their worth.

Potential for Growth: Investors are interested in the future. Hospitals with plans to expand, introduce new services, or reach new patient groups are seen as more valuable.

Strategic Location & Catchment Area: A hospital’s geographic placement and the demographics of its surrounding patient population are crucial for accessibility, patient volume, and ultimately, its valuation.

Reputation and Trust: A hospital’s good name, the loyalty of its patients, and the trust people have in its medical staff are valuable assets that contribute to its overall worth.

Why Some Hospitals Get Higher Valuations:

Focus on Profitable Specialties: Hospitals specializing in high-demand and high-margin areas like heart care, cancer treatment, brain surgery, and fertility often command higher prices.

Strong Brand and Trust: Hospitals known for excellent medical care and positive patient experiences are more valuable.

Good Locations: Hospitals in major cities or areas with a large number of insured patients tend to have better revenue and higher valuations.

Consistent Growth: Hospitals that have shown a steady increase in revenue and profits, with clear plans for future expansion, are attractive to buyers.

Efficient Operations: Well-managed hospitals that use their resources effectively are more profitable and thus more valuable.

Emerging Markets: The growing healthcare awareness and increasing disposable incomes in Tier II and Tier III cities are making hospitals in these locations increasingly attractive to investors, presenting significant growth potential.

Why Some Hospitals Might Have Lower Valuations:

Financial Problems: Hospitals struggling with low patient numbers, high costs, or significant debt are usually valued lower.

Inefficient Operations: Poor management and outdated facilities can negatively impact a hospital’s worth.

Regulatory Issues: A history of not following regulations or facing legal challenges can reduce a hospital’s value.

Strong Competition: Hospitals in areas with many competitors might face pressure on pricing and profitability, leading to lower valuations.

Heavy Reliance on Government Schemes with Low Payments: While treating a large number of patients through government schemes can provide volume, the lower reimbursement rates can affect profitability and overall value.

Examples from FY 2025 and What They Tell Us

The deals announced in the financial year 2025 offer tangible insights into how the valuation factors discussed earlier play out in real-world scenarios.

General Atlantic’s Investment in Ujala Cygnus: Information suggests General Atlantic invested in Ujala Cygnus at an enterprise value of approximately ₹1600 crore, translating to a valuation of around ₹64 lakhs per bed. This per-bed valuation appears comparatively lower than some other deals witnessed during the year. Ujala Cygnus’s focus on Tier II and Tier III cities, which typically have a lower ARPOB (Average Revenue Per Occupied Bed), likely contributes to this. While the growth potential of these emerging markets attracts investors, the valuation may remain somewhat conservative compared to hospitals in more established urban centers.

KKR’s Acquisition of Majority Stake in HCG: KKR’s acquisition of a majority stake in HealthCare Global Enterprises (HCG) is reported to have been at an attractive valuation. This deal also underscores the strong potential and investor interest in the oncology segment within the Indian healthcare market in the coming years. Similarly, valuation of Omega healthcare also indicates perceived potential of oncology business in India.

Transaction Month Acquirer Target Location % of stake Valuation in Cr Valuation per beds Revenue Multiple EBIDTA Multiple Remarks
Apr-24 General Atlantic Ujala Cygnus Northern India (Tier-II and Tier-III cities) 70% 1,600 0.64 2.78 21.33 Tier II and III cities presence
Apr-24 Manipal Hospitals Medica Synergie Kolkata 87% 1,609 1.61 2.63 13.17 Strengthens Manipal's presence in eastern India
Jun-24 HealthCare Global Enterprises Ltd (HCG) Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) Visakhapatnam 51% initially (to increase to 85% in 18 months) 414 2.11 3.45 9.86
Jun-24 Morgan Stanley Omega Hospitals South India 23% 2,100 1.50 FY 24 data is not avaialble. Multiple seems high based FY 23 revenue and EBIDTA
Jul-24 KKR Baby Memorial Hospital (BMH) South India 70% 2,500 2.50 6.08 31.03
Jul-24 MGM Healthcare Seven Hills Hospital Visakhapatnam 100% 171 0.57 Acquired through the CIRP
Jul-24 Krishna Institute of Medical Sciences Ltd (KIMS) Chalasani Hospitals Private Ltd (QNRI) Visakhapatnam 100% 75 0.38 With real estate - Land 1.5 lacs sq ft
Aug-24 Peerless Group SKM Hospital Barasat 100% NA Data not available
Sep-24 Max Healthcare Jaypee Hospital life first Noida, Bulandshahr, Anoopshahr 64% 1660 2.37 3.94 23.71 Acquisition thru debt repayment of Rs. 1000 cr
Oct-24 Yatharth Hospital and Trauma Care Services Ltd MGS Infotech Research and Solutions Private Ltd Faridabad 60% 152 0.38 Expected to be operatoinal in 6-10 mths after acquisition
Oct-24 Yatharth Hospital MD City Hospital Model Town, New Delhi 100% 160 0.53 Acquired through SARFAESI Act e-auction
Oct-24 Manipal Hospitals Khubchandani Hospital Andheri, Mumbai 100% 415 0.83 Acquisition focus on real estate - 2.6 acre land , 2 lacs + sq ft BU area
Feb-25 Fortis Healthcare Shrimann Superspecialty Hospital Jalandhar, Punjab 100% 462 2.03 3.00 12.83 Revenue and EBiDTA multiple- expected for FY 25
Feb-25 KKR HCG Pan India 54% 6417 2.57 3.20 18.00
These examples from FY 2025 illustrate the diverse factors influencing hospital valuations in India. From the focus on emerging markets to the high growth expectations for specialized segments like oncology, each deal provides a unique lens through which to understand the complexities of valuation in this dynamic industry.

How Hospital Values Are Really Determined: Beyond the Numbers

While financial formulas give us a starting point, the final value of a hospital in an M&A deal is often a result of several factors beyond just the numbers:

Negotiation:

The final price is what the buyer and seller agree on. Their negotiating power, how urgently they need to complete the deal, and whether there are other interested buyers all play a role.
Using Different Approaches:
Buyers and sellers usually look at value using several methods to get a more complete picture. This helps them understand a reasonable price range.
Strategic Fit:
How well the hospital fits with the buyer’s overall plans is crucial. A hospital that helps the buyer enter a new market or offer new services might be worth more to them.
Reputation and Quality:
A hospital’s good reputation and the quality of its doctors and staff are valuable assets that formulas don’t always fully capture.
Future Potential:
Opportunities for growth, even if not immediately obvious in financial projections, can increase a hospital’s value.

Synergies:

The potential for the buyer to save money or increase revenue by combining the acquired hospital with their existing business is a major factor driving the price they are willing to pay.

In Conclusion

Valuing a hospital in India for a merger or acquisition is a complex process. While financial analysis is important, the final value is often shaped by negotiation, looking at value from different angles, and considering the strategic fit and future potential of the hospital. As the Indian healthcare industry continues to grow and consolidate, understanding these factors, along with comprehensive financial planning and analysis services, will be crucial for everyone involved.